non-Hodgkin lymphomas
A Physiological Study of Albumin Level for Patients with Non-Hodgkin Lymphomas
... Cancer is a major public health problem in different countries around the world. Recent studies reported by the World Health Organization (WHO) expected that cancer will affect approximately 15 million people at the ...
6
Clinicopathological Properties of Non-Hodgkin Lymphomas in the South-West of Turkey
... Objective: Non-Hodgkin Lymphomas, which have numerous histological subgroups, entail various biological behaviour, clinical properties and epidemiological ...of Non-Hodgkin Lymphoma ...
5
Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study
... The databases of PubMed, Web of Science, Elsevier, HighWire, Scopus, and Google Scholar were searched up to May 2015 using the following terms: “TNF-308G.A polymorphism, rs1800629, or tumor necrosis factor-alpha” and ...
14
HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas
... lignant lymphomas, 95% of which are of B-cell ...B-cell lymphomas may be positively stained by an anti-Tat antibody [21] and again here we show positivity for Tat in our set of B-cell ...
18
Apoptosis inhibition or inflammation: the role of NAIP protein expression in Hodgkin and non-Hodgkin lymphomas compared to non-neoplastic lymph node
... Surprisingly, we found significantly different expres- sion of NAIP between the RLH lymph nodes and the same number normal lymph nodes in the control group. Considering our finding and taking into account the fact that ...
9
Evaluation of Prognostic Indicators in Non Hodgkin Lymphomas: The Role of Apoptotic and Proliferative Indices
... 119 Non Hodgkin lymphoma patients using a panel of CD3,5,10,20,23,30,38,79a,138, bcl- 2, MUM1/IRF4, cyclinD1 and Ki-67/Mib1 ...cell lymphomas are done by basic panel of markers such as CD5, 23, 10, ...
118
Gastrointestinal non-Hodgkin lymphomas
... in non-Hodgkin lymphoma (NHL), primary gastrointestinal NHL (gNHL) is a rare problem which concerns about 10–15% of NHL patients and 30–40% of extranodal NHL ...other lymphomas may be found in the GI ...
6
<p>A Retrospective Analysis of Primary Gastrointestinal Non-Hodgkin Lymphomas: Clinical Features, Prognostic Factors and Treatment Outcomes</p>
... Sequential dual-color immunohistochemistry (IHC) assays were performed with the target markers Myc, Bcl2 and Bcl6. The cutoff values for the positivity of BCL6 and MYC were ≥ 40% and BCL2 ≥ 70%, respectively. For ...
8
Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas
... Results Inhibition of PIM kinases has a minor effect on BL and ABC-DLBCL cell viability The high level of expression of PIM1 and PIM2 in ABCDLBCL Additional file 1: Figure S1 and the rep[r] ...
14
Case Report Low-grade Epstein-Barr virus positive plasma cell proliferations of precursor plasma cell origin: report of two cases
... cell non-Hodgkin lymphomas with extensive plasmacytic differentiation without detailed immunophenotyping and EBV studies, if the diagnosis is solely based on the morphologic features and the low ...
6
Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018
... Early incidence rates for cancer in Lebanon were provided by Abou-Daoud in 1966. Cancer rates were reported at 102.8 and 104.1 per 100,000 for males and females, re- spectively [11]. The study observed high incidence of ...
8
Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
... and Hodgkin and Non-Hodgkin lymphomas is strongly supported by epidemiological ...with Hodgkin, Non- Hodgkin`s ...
6
CBC Finding and LDH Estimation in Newly Diagnosed Patients with NHL
... 3 / Peveling-Oberhag J, Arcaini L, Hansmann ML, Zeuzem S (2013). "Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management". Journal of ...
14
EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda
... Background: B cell non Hodgkin lymphomas account for the majority of lymphomas in Uganda. The commonest is endemic Burkitt lymphoma, followed by diffuse large-B-cell lymphoma (DLBCL). There ...
7
Differences in routine laboratory parameters related to cachexia between patients with hematological diseases and patients with solid tumors or heart failure – is there only one cachexia?
... and non- cachectic groups of ...or non-hematological groups, although we are well aware of the relatively small number of patients in groups and of the variability of patients ’ diagnoses especially in the ...
8
Pediatric Non Hodgkin’s Lymphomas
... Dramatic improvement has been obtained in the past ten years in cure rate of children with NHL, particularly B-cell lymphomas. This is due in great part to prospective well conducted national multi- center ...
6
A REVIEW ON BREAST CANCER
... Women who, as children or young adults, had radiation therapy to the chest area as treatment for another cancer (such as Hodgkin disease or non-Hodgkin lymphoma)[r] ...
17
Review Article Pitfalls in diagnostic hematopathology – Part II
... variants (Figure 1A), are collectively called Hodgkin-Reed-Sternberg (HRS) cells in memory of the three pioneers in the description and diagnosis of cHL [3-5]. Recent investigation suggests that HRS cells are bona ...
8
Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma
... The expressions CD20, CD79a, PAX5, CD10, MUM1 and TDT were evaluated for positivity or negativity. The markers Myc, Bcl2 and Bcl6 were assessed for percent- age of cellular expression. For Myc and BCL6, biopsies were ...
9
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma
... the Hodgkin/ Reed-Sternberg (HRS) cells of CHL and quite a few tumor cells in PMLBCL express ...two lymphomas exhibit a spectrum of histopathologic and immunophenotypic diversity based on the plasticity of ...
7